Concourse Financial Group Securities, Inc. Orgenesis Inc. Put Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding ORGS
# of Institutions
20Shares Held
1.61MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA910KShares$3.96 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA283KShares$1.23 Million0.0% of portfolio
-
Black Rock Inc. New York, NY79.9KShares$347,5170.0% of portfolio
-
State Street Corp Boston, MA78.9KShares$343,1190.0% of portfolio
-
Ronit Capital LLP54.2KShares$235,6260.1% of portfolio
About Orgenesis Inc.
- Ticker ORGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,545,800
- Market Cap $111M
- Description
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...